Cargando…
Inhibition of selenoprotein synthesis is not the mechanism by which auranofin inhibits growth of Clostridioides difficile
Clostridioides difficile infections (CDIs) are responsible for a significant number of antibiotic-associated diarrheal cases. The standard-of-care antibiotics for C. difficile are limited to fidaxomicin and vancomycin, with the recently obsolete metronidazole recommended if both are unavailable. No...
Autores principales: | Johnstone, Michael A., Holman, Matthew A., Self, William T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484987/ https://www.ncbi.nlm.nih.gov/pubmed/37679389 http://dx.doi.org/10.1038/s41598-023-36796-9 |
Ejemplares similares
-
In vivo efficacy of auranofin in a hamster model of Clostridioides difficile infection
por: Abutaleb, Nader S., et al.
Publicado: (2021) -
Exposure to Silver Nanoparticles Inhibits Selenoprotein Synthesis and the Activity of Thioredoxin Reductase
por: Srivastava, Milan, et al.
Publicado: (2011) -
Evaluation of Derivatives
of (+)-Puupehenone against Clostridioides difficile and Other Gram-Positive
Bacteria
por: Johnstone, Michael A., et al.
Publicado: (2022) -
Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection
por: Abutaleb, Nader S., et al.
Publicado: (2020) -
Using CRISPR-Cas9-mediated genome editing to generate C. difficile mutants defective in selenoproteins synthesis
por: McAllister, Kathleen N., et al.
Publicado: (2017)